4.5 Article

Emergence of serotype 10A-ST11189 among pediatric invasive pneumococcal diseases, South Korea, 2014-2019

Journal

VACCINE
Volume 39, Issue 40, Pages 5787-5793

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.vaccine.2021.08.072

Keywords

Streptococcus pneumoniae; Serotype; Genotype; Children

Funding

  1. 2018 Seoul National University Hospital Research Fund [0420180490]
  2. Research Program - Korea Disease Control and Prevention Agency [2018E240600]

Ask authors/readers for more resources

After the introduction of extended-valency pneumococcal conjugate vaccines, the replacement with nonvaccine serotypes among invasive pneumococcal diseases varies by country. In South Korea, the most common nonvaccine serotype in pediatric IPD cases was 10A, with a significant increasing trend over the study period. Other nonvaccine serotypes showed a decreasing trend, with notable reductions in serotype 12F.
Replacement with nonvaccine serotypes (NVTs) among invasive pneumococcal diseases (IPDs) after the introduction of extended-valency pneumococcal conjugate vaccines varies in predominant serotypes across countries. This study analyzed changes in serotype distribution through serotyping, multilocus sequence typing, and antimicrobial susceptibility testing of 168 pediatric IPD isolates obtained from a multihospital-based surveillance system during 2014-2019 in South Korea. Vaccine serotypes (VTs) accounted for 16.1% (19A, 10.1%; 6A, 1.8%; and 19F 1.8%), 82.1% were NVTs (10A, 23.8%; 15A, 8.3%; 12F, 6.5%; 15C, 6.5%; and 15B, 6.0%), and three (1.8%) were nontypeable. Serotype 10A was the most com-mon serotype, with a significant increase from 11.5% in 2014 to 33.3% in 2019 (p < 0.05 for the trend). Other NVTs decreased from 70.4% to 41.7% between 2015 and 2019, most notably in serotype 12F (from 14.8% to 0%). Almost all (95.0%) serotype 10A isolates were ST11189, which were multidrug resistant. (c) 2021 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available